The Bosnian & Herzegovinan Competition Authority prosecutes regional Government for intervening with competitive process on the market for pharmaceuticals reimbursed under the national health insurance scheme (Association of Foreign Pharmaceutical Producers in Bosnia & Herzegovina / Cantonal Government Sarajevo)

Summary Competition Authority of Bosnia & Herzegovina qualified the actions of the Sarajevo cantonal government that provided preferential treatment to the domestically produced medicines under the national health insurance scheme as anticompetitive practice and ordered it to modify its decisions in this respect. The infringement of the competition law consisted in the cantonal government's decision to replace any foreign medicines by equivalent domestically produced one, which deprived foreign producers and exporters from the benefits of the state reimbursement under the national health insurance scheme. Facts Under the national health insurance scheme [1] in Bosnia & Herzegovina the cantonal governments established the list of the approved medicines that can be sold to the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • University of Macau - Faculty of Law (Macau)

Quotation

Alexandr Svetlicinii, The Bosnian & Herzegovinan Competition Authority prosecutes regional Government for intervening with competitive process on the market for pharmaceuticals reimbursed under the national health insurance scheme (Association of Foreign Pharmaceutical Producers in Bosnia & Herzegovina / Cantonal Government Sarajevo), 22 October 2008, e-Competitions October 2008, Art. N° 26125

Visites 1650

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues